|
Market Closed -
NYSE
01:30:02 26/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.040 USD | +7.76% |
|
+0.97% | -70.54% |
| 14/08 | ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says | MT |
| 14/08 | ADC Therapeutics SA, Q2 2026 Earnings Call, Aug 13, 2026 |
Chart: Technical Analysis
Stock exchange
NYSE
ADCT 1.040 $
+7.76%
40.85L
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| ADCT | 1.040USD | +7.76% | 40.85L $ | |
CBOE
| ADCT | 1.030USD | +6.09% | 96.83T $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.13 | 2.12 | 2.03 |
| Spread/Res. | -7.96% | -50.94% | -48.77% |
| Spread/Supp. | +8.32% | +8.32% | +4.35% |
| Support | 0.9601 | 0.9601 | 0.9966 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADCT Stock
- Charts ADC Therapeutics SA
Select your edition
All financial news and data tailored to specific country editions
